HIV acquisition during pregnancy and postpartum is associated with genital infections and partnership characteristics
- PMID: 26352880
- PMCID: PMC4692052
- DOI: 10.1097/QAD.0000000000000793
HIV acquisition during pregnancy and postpartum is associated with genital infections and partnership characteristics
Abstract
Objective: The objective of this study is to determine the risk and cofactors for HIV acquisition during pregnancy and postpartum.
Design: A prospective cohort study
Methods: : Pregnant women in western Kenya were enrolled if HIV seronegative at that visit or within 3 months. Serial HIV nucleic acid amplification tests (NAATs) were conducted at 1 to 3-month intervals to 9 months postpartum. Genital swabs were collected for detection of chlamydia and gonorrhoea at baseline, and for trichomonas, bacterial vaginosis and yeast at baseline and follow-up.
Results: Among 1304 pregnant women, median age was 22 years, 78% were married for a median of 4 years, 66% reported knowing partner HIV status and 8% reported using condoms. Study retention was 98%. During 1235 person-years of follow-up, HIV incidence was 2.31/100 person-years [95% confidence interval (95% CI) 0.71-4.10]. Incident HIV was associated with syphilis (hazard ratio 9.18, 95% CI 2.15-39.3), chlamydia (hazard ratio 4.49, 95% CI 1.34-15.0), bacterial vaginosis (hazard ratio 2.91, 95% CI 1.25-6.76), yeast (hazard ratio 3.46, 95% CI 1.46-8.19), sexually transmitted infection (STI) history (hazard ratio 3.48, 95% CI 1.31-9.27), lifetime number of sex partners (hazard ratio 1.19, 95% CI 1.03-1.37), partner age discordance (hazard ratio 1.07 per year, 95% CI 1.02-1.13) and shorter marriage (hazard ratio 1.19 per year, 95% CI 1.03-1.38). No women with incident HIV reported an HIV-infected partner. In multivariate analyses, chlamydia, older partners and yeast infection remained significant; however, power was limited.
Conclusion: Pregnant and lactating women may not perceive HIV risk and rarely used condoms. Prevention and treatment of genital infections and risk stratification to identify women for pre-exposure prophylaxis (PrEP) could decrease HIV acquisition in pregnant/lactating women.
Conflict of interest statement
Competing interests
The authors declare that no competing interests exist
Figures



Comment in
-
Understanding risk factors for incident maternal HIV-1 infection.AIDS. 2015 Sep 24;29(15):2053-4. doi: 10.1097/QAD.0000000000000803. AIDS. 2015. PMID: 26352881 No abstract available.
Similar articles
-
Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study.AIDS. 1993 Jan;7(1):95-102. doi: 10.1097/00002030-199301000-00015. AIDS. 1993. PMID: 8442924
-
Chlamydia, Gonorrhea, and Incident HIV Infection During Pregnancy Predict Preterm Birth Despite Treatment.J Infect Dis. 2021 Dec 15;224(12):2085-2093. doi: 10.1093/infdis/jiab277. J Infect Dis. 2021. PMID: 34023871 Free PMC article.
-
Primary HIV prevention in pregnant and lactating Ugandan women: A randomized trial.PLoS One. 2019 Feb 25;14(2):e0212119. doi: 10.1371/journal.pone.0212119. eCollection 2019. PLoS One. 2019. PMID: 30802277 Free PMC article. Clinical Trial.
-
Changes in the contribution of genital tract infections to HIV acquisition among Kenyan high-risk women from 1993 to 2012.AIDS. 2015 Jun 1;29(9):1077-85. doi: 10.1097/QAD.0000000000000646. AIDS. 2015. PMID: 26125141 Free PMC article.
-
Population-based interventions for reducing sexually transmitted infections, including HIV infection.Cochrane Database Syst Rev. 2004;(2):CD001220. doi: 10.1002/14651858.CD001220.pub2. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2011 Mar 16;(3):CD001220. doi: 10.1002/14651858.CD001220.pub3. PMID: 15106156 Updated. Review.
Cited by
-
Optimizing HIV retesting during pregnancy and postpartum in four countries: a cost-effectiveness analysis.J Int AIDS Soc. 2021 Apr;24(4):e25686. doi: 10.1002/jia2.25686. J Int AIDS Soc. 2021. PMID: 33787064 Free PMC article.
-
Targeted Pregnancy and Human Immunodeficiency Virus Prevention Risk-Reduction Counseling for Young Women: Lessons Learned from Biomedical Prevention Trials.J Infect Dis. 2018 Oct 20;218(11):1759-1766. doi: 10.1093/infdis/jiy388. J Infect Dis. 2018. PMID: 29947802 Free PMC article.
-
The incidence of HIV and associated risk factors among pregnant women in Kabarole District, Uganda.PLoS One. 2020 Jun 5;15(6):e0234174. doi: 10.1371/journal.pone.0234174. eCollection 2020. PLoS One. 2020. PMID: 32502227 Free PMC article.
-
The role of costing in the introduction and scale-up of HIV pre-exposure prophylaxis: evidence from integrating PrEP into routine maternal and child health and family planning clinics in western Kenya.J Int AIDS Soc. 2019 Jul;22 Suppl 4(Suppl Suppl 4):e25296. doi: 10.1002/jia2.25296. J Int AIDS Soc. 2019. PMID: 31328443 Free PMC article.
-
Risk-based versus universal PrEP delivery during pregnancy: a cluster randomized trial in Western Kenya from 2018 to 2019.J Int AIDS Soc. 2023 Feb;26(2):e26061. doi: 10.1002/jia2.26061. J Int AIDS Soc. 2023. PMID: 36807505 Free PMC article. Clinical Trial.
References
-
- UNAIDS. Global report: UNAIDS report on the global AIDS epidemic 2013. Genva: 2013.
-
- World Health Organization. Consolidated guidelines on the use of antriretroviral drugs for treating and preventing HIV infection. Geneva: World Health Organizaion; 2013. http://www.who.int/hiv/pub/guidelines/arv2013/en/ [Accessed 18 May 2015] - PubMed
-
- UNAIDS. The Gap Report. 2014
-
- Gray R, Li X, Kigozi G, Serwadda D, Brahmbhatt H, Wabwire-Mangen F, et al. Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study. Lancet. 2005;366:1182–1188. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous